News
HC Wainwright & Co. Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $8
10 May 24
News, Price Target, Analyst Ratings
CARISMA Therapeutics Q1 2024 GAAP EPS $(0.46) Misses $(0.43) Estimate
9 May 24
Earnings, Earnings Misses, News
Carisma Therapeutics To Present New Data At ASGCT Annual Meeting
22 Apr 24
Biotech, News, Events, General
BTIG Initiates Coverage On CARISMA Therapeutics with Buy Rating, Announces Price Target of $6
11 Apr 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on CARISMA Therapeutics, Lowers Price Target to $9
2 Apr 24
News, Price Target, Analyst Ratings
CARISMA Therapeutics Q4 EPS $(0.52) Beats $(0.55) Estimate, Sales $4.29M Beat $2.90M Estimate
1 Apr 24
Earnings, Earnings Beats, News
Press releases
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
9 May 24
Earnings, Penny Stocks, Press Releases
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
8 May 24
Penny Stocks, Press Releases
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
6 May 24
Penny Stocks, Press Releases
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
2 May 24
Penny Stocks, Press Releases
Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
24 Apr 24
Penny Stocks, Press Releases
Carisma Therapeutics to Present at Upcoming Conferences
3 Apr 24
Penny Stocks, Press Releases
Carisma Therapeutics Announces Changes to its Board of Directors
1 Apr 24
Penny Stocks, Press Releases
Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
21 Mar 24
Penny Stocks, Press Releases
Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference
28 Feb 24
Penny Stocks, Press Releases